更正：通过抑制p38丝裂原活化蛋白激酶逆转结肠癌细胞系对奥沙利铂的耐药性：钙蛋白酶/Nox1途径的参与

1

Oncotarget. 2018 Jun 1;9(42):26978-26979. doi: 10.18632/oncotarget.25605.

2

Oncotarget. 2017 Oct 10;8(61):103710-103730. doi: 10.18632/oncotarget.21780. eCollection 2017 Nov 28.

3

Cell Signal. 2016 Aug;28(8):924-36. doi: 10.1016/j.cellsig.2016.04.007. Epub 2016 Apr 20.

4

Oncotarget. 2018 Apr 6;9(26):18664. doi: 10.18632/oncotarget.25142.

5

Oncotarget. 2020 Sep 15;11(37):3484-3485. doi: 10.18632/oncotarget.27605.

6

Apoptosis. 2016 Aug;21(8):896-904. doi: 10.1007/s10495-016-1263-0.

7

Oncotarget. 2018 Jun 19;9(47):28796. doi: 10.18632/oncotarget.25677.

8

Int J Oncol. 2011 Jun;38(6):1695-702. doi: 10.3892/ijo.2011.982. Epub 2011 Mar 21.

9

Int J Cancer. 2016 May 15;138(10):2466-76. doi: 10.1002/ijc.29980. Epub 2016 Jan 11.

10

Oncotarget. 2019 Sep 3;10(51):5385-5386. doi: 10.18632/oncotarget.27186.

Correction: Reversion of resistance to oxaliplatin by inhibition of p38 MAPK in colorectal cancer cell lines: involvement of the calpain / Nox1 pathway.